MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-03-0000082
Meticue Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.26 Cr
▲ 23% YoY
Net loss · FY 2025
₹40.81 Lakh
Net margin -32.5%
EBITDA · FY 2025
-₹40.6 Lakh
EBITDA margin -32.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Meticue Pharmaceuticals Private Limited
Data last updated:
Meticue Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2020PTC363628. Its GSTIN is 20AANCM4271H1ZK (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Suman Kumar and Prem Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 171 Ganesh Nagar Pandav Nagar Complex, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.26 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹40.81 Lakh (net margin -32.5%) and EBITDA of -₹40.6 Lakh (EBITDA margin -32.3%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.
Meticue Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0000082). For more details, the company can be reached via its website meticuepharma.com.
Company details
CIN U33100DL2020PTC363628
Registration Number 363628
Incorporation Date 08 May 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0000082
Key People
Suman Kumar Director Prem Kumar Mishra Director Recognitions & Rankings of Meticue Pharmaceuticals
Contact details
Meticue Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is meticuepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 171 Ganesh Nagar Pandav Nagar Complex, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Meticue Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Meticue Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meticue Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meticue Pharmaceuticals Private Limited, buy the company report.
Financials of Meticue Pharmaceuticals Private Limited
FY 2025 filings availableMeticue Pharmaceuticals Private Limited reported revenue of ₹1.26 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹1.26 Cr ▲ 23%
Net loss · FY 2025
₹40.81 Lakh margin -32.5%
EBITDA · FY 2025
-₹40.6 Lakh margin -32.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▼ 25%
Revenue has grown at a compounded annual rate (CAGR) of 52% over three years, including 23% growth in the latest year. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹40.6 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹40.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -32.3% | ||||
| Net Profit Margin | -32.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meticue Pharmaceuticals Private Limited, buy the company report.
Board of directors of Meticue Pharmaceuticals Private Limited
Meticue Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Kumar | Director | 08 May 2020 | 6 Years 5 Months | Current |
| Prem Kumar Mishra | Director | 08 May 2020 | 6 Years 5 Months | Current |
Peer comparison
Meticue Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Narix Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | 61.0% | Mumbai, Maharashtra, India | |||
| Douglas Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2025) | -18.0% | Hyderabad, Telangana, India | |||
| Demexico Pharmaceuticals Private Limited | ₹1.26 Cr (FY 2024) | 5.0% | Dehradun, Uttarakhand, India | |||
| Meticue Pharmaceuticals Private Limitedthis company | ₹1.26 Cr (FY 2025) | -₹40.81 Lakh | -32.5% | 23.0% | New Delhi, Delhi, India | |
| Zoydec Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 19.0% | Chandigarh, India | |||
| Revanex Pharmaceuticals Private Limited | ₹1.25 Cr (FY 2025) | 187.0% | Siliguri, West Bengal, India |
To see the full peer comparison of Meticue Pharmaceuticals Private Limited, buy the company report.
Auditor
Meticue Pharmaceuticals Private Limited is audited by PRAHLAD & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAHLAD & CO. | FY 2023 | 019485C |
Shareholding
The shareholding of Meticue Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Meticue Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meticue Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meticue Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Meticue Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
Meticue Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AANCM4271H1ZK | Jharkhand | Active | 29 Jul 2020 |
To see the full GST registrations and return filing status of Meticue Pharmaceuticals Private Limited, buy the company report.
Recent activity
Meticue Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Prem Kumar Mishra was appointed as Director on 08 May 2020.
AGM
Meticue Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Meticue Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Prem Kumar Mishra was appointed as Director.
Appointed
Suman Kumar was appointed as Director.
Incorporation
08 May 2020
Meticue Pharmaceuticals Private Limited was registered on 08 May 2020 with Roc Delhi I & aged 6 years 5 months as per MCA records.
Frequently asked questions
Meticue Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 May 2020 (6+ years old) and is registered under CIN U33100DL2020PTC363628.
Meticue Pharmaceuticals has 2 current directors:
- Suman Kumar - Director
- Prem Kumar Mishra - Director
The latest financial statements of Meticue Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Meticue Pharmaceuticals is 20AANCM4271H1ZK, registered in Jharkhand.
The CIN (Corporate Identification Number) of Meticue Pharmaceuticals is U33100DL2020PTC363628. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meticue Pharmaceuticals was incorporated on 08 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Meticue Pharmaceuticals by revenue are Narix Pharmaceuticals Private Limited, Douglas Pharmaceuticals Private Limited, Demexico Pharmaceuticals Private Limited, Zoydec Pharmaceuticals Private Limited, Revanex Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prem Kumar Mishra was appointed as Director on 08 May 2020. Suman Kumar was appointed as Director on 08 May 2020.
Yes, Meticue Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0000082).
Meticue Pharmaceuticals can be reached through the website meticuepharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Meticue Pharmaceuticals is at D – 171 Ganesh Nagar Pandav Nagar Complex, New Delhi, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages